These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 3702542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
    Ogawa T, Kotani S, Shimauchi H.
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B, Finger H, Wirsing CH.
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ, Xu S, Liao XY, Zhang SD, Liang ZL, Liu BH, Bai JY, Jiang C, Ding J, Cheng GF, Liu G.
    J Med Chem; 2005 Aug 11; 48(16):5112-22. PubMed ID: 16078831
    [Abstract] [Full Text] [Related]

  • 7. Humoral immune response to Bacteroides gingivalis fimbrial antigen in mice.
    Ogawa T, Shimauchi H, Kusumoto Y, Hamada S.
    Immunology; 1990 Jan 11; 69(1):8-13. PubMed ID: 1968885
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of non-specific resistance to infection by muroctasin.
    Otani T, Une T, Osada Y.
    Arzneimittelforschung; 1988 Jul 11; 38(7A):969-76. PubMed ID: 3056426
    [Abstract] [Full Text] [Related]

  • 9. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
    Ishihara C, Yamamoto K, Hamada N, Azuma I.
    Vaccine; 1984 Dec 11; 2(4):261-4. PubMed ID: 6531965
    [Abstract] [Full Text] [Related]

  • 10. Genetic influences on the adjuvanticity of muramyl dipeptide in vivo.
    Staruch MJ, Wood DD.
    J Immunol; 1982 Jan 11; 128(1):155-60. PubMed ID: 6976368
    [Abstract] [Full Text] [Related]

  • 11. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
    Nagao S, Sato K, Osada Y.
    Jpn J Cancer Res; 1987 Jan 11; 78(1):80-6. PubMed ID: 3102442
    [Abstract] [Full Text] [Related]

  • 12. Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingivalis fimbriae administered orally.
    Ogawa T, Shimauchi H, Hamada S.
    Infect Immun; 1989 Nov 11; 57(11):3466-71. PubMed ID: 2572554
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo augmentation by muroctasin of the production of the third component of complement by murine macrophages.
    Endo N.
    Arzneimittelforschung; 1988 Jul 11; 38(7A):993-6. PubMed ID: 3190805
    [Abstract] [Full Text] [Related]

  • 14. Mutagenicity studies of muroctasin.
    Shimada H, Hattori C, Sato T.
    Arzneimittelforschung; 1988 Jul 11; 38(7A):1031-3. PubMed ID: 3056424
    [Abstract] [Full Text] [Related]

  • 15. Activation of immune responses by muroctasin.
    Akasaki M.
    Arzneimittelforschung; 1988 Jul 11; 38(7A):976-7. PubMed ID: 3056427
    [Abstract] [Full Text] [Related]

  • 16. Oral immunoadjuvant activity of lipophilic derivatives of N-acetylglucosaminyl-beta(1-->4)-N-acetylmuramyl-L-alanyl-D-isoglutamin yl-(L)- 2,6-meso-diaminopimeric acid-(D)-amide.
    Ogawa T, Shimauchi H, Furuta R, Kawata S, Yokogawa K, Kotani S.
    Vaccine; 1995 Jul 11; 13(10):887-9. PubMed ID: 7483759
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    Lowy I, Theze J, Chedid L.
    J Immunol; 1980 Jan 11; 124(1):100-4. PubMed ID: 6965289
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of plasma fibronectin production in mice by muroctasin.
    Endo N, Okuda T, Osada Y, Zen-Yoji H.
    Arzneimittelforschung; 1988 Jul 11; 38(7A):997-8. PubMed ID: 3190806
    [Abstract] [Full Text] [Related]

  • 19. Biotransformation of muroctasin in mice.
    Matsubayashi K, Takegoshi T.
    Arzneimittelforschung; 1988 Jul 11; 38(7A):1015-8. PubMed ID: 3190793
    [Abstract] [Full Text] [Related]

  • 20. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
    Audibert F, Przewlocki G, Lefrancier P, Choay J, Chedid L.
    C R Seances Acad Sci III; 1982 Nov 22; 295(10):611-4. PubMed ID: 6218866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.